NCT05924932View on ClinicalTrials.gov

Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 1, 2023

Study Completion Date

May 1, 2024

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Tandem t:slim X2 with hybrid closed loop system Control IQ, glucose sensor: Dexcom G6

type of hybrid close loop insulin delivery system

DEVICE

MiniMed 780G, with hybrid closed loop system SmartGuard, sensor Guardien 4

type of hybrid close loop insulin delivery system

Trial Locations (1)

401 13

RECRUITING

Lucie Radovnická, Ústí nad Labem

All Listed Sponsors
lead

Masaryk Hospital Usti nad Labem

OTHER